Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park
Close-out letter issued October 9, 2020 · Raichur, India
- Pages
- 8
- FEI number
- 3009876430
In short: On October 9, 2020, FDA sent Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park in Raichur, Karnataka (FEI 3009876430) a close-out letter, confirming that the issues in an earlier warning letter were addressed.
Inside this close-out letter
The full close-out letter
Every page of the close-out letter, exactly as written.
Get the full close-out letterThis inspection in context
Questions about this close-out letter
When was Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park inspected by FDA?
This Close-out letter is dated October 9, 2020.
How do I get the full Close-out letter for Shilpa Medicare Limited S-20 to S-26 Pharma. Formulations SEZ; TSIIC, Green Ind. Park?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.